Article Text

Download PDFPDF
The effectiveness of anti-illicit-drug public-service announcements: a systematic review and meta-analysis
  1. Dan Werb1,
  2. Edward J Mills1,2,
  3. Kora DeBeck1,
  4. Thomas Kerr1,3,
  5. Julio S G Montaner1,3,
  6. Evan Wood1,3
  1. 1British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
  2. 2Faculty of Health Sciences, Simon Fraser University, Vancouver Canada
  3. 3Department of Medicine, University of British Columbia, Vancouver, Canada
  1. Correspondence to Evan Wood, BC Centre for Excellence in HIV/AIDS, Department of Medicine, University of British Columbia 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada; uhri-ew{at}cfenet.ubc.ca

Footnotes

  • Funding Michael Smith Foundation for Health Research; Canadian Institutes of Health Research.

  • Competing interests EM has received grants and served as an ad hoc advisor to Pfizer, and JM has received grants from, served as an ad hoc adviser to, or spoken at events sponsored by Abbott, Argos Therapeutics, Bioject, Boehringer Ingelheim, BMS, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen-Ortho, Merck Frosst, Panacos, Pfizer, Schering, Serono, TheraTechnologies, Tibotec (J&J) and Trimeris.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Funding Michael Smith Foundation for Health Research; Canadian Institutes of Health Research.

  • Competing interests EM has received grants and served as an ad hoc advisor to Pfizer, and JM has received grants from, served as an ad hoc adviser to, or spoken at events sponsored by Abbott, Argos Therapeutics, Bioject, Boehringer Ingelheim, BMS, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen-Ortho, Merck Frosst, Panacos, Pfizer, Schering, Serono, TheraTechnologies, Tibotec (J&J) and Trimeris.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.